Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare and severe condition that predominantly affects individuals with end-stage kidney disease (ESKD). It manifests through vascular calcifications that precipitate tissue necrosis, with cutaneous manifestations being common. However, gastrointestinal involvement is an infrequent but gravely serious occurrence. In this report, we present an atypical case of gastrointestinal (GI) calciphylaxis in a 66-year-old woman undergoing peritoneal dialysis. The patient's initial symptoms of abdominal pain and turbid peritoneal fluid raised suspicions of bacterial peritonitis. Despite therapeutic interventions, the patient's condition deteriorated. Computed tomography (CT) imaging revealed a perforation in the caecal wall, necessitating emergency surgical intervention. Histopathology post-surgery confirmed the diagnosis of GI calciphylaxis. The patient's postoperative trajectory was fraught with complications, ultimately leading to a fatal outcome. This case highlights the importance of vigilance for calciphylaxis in the differential diagnosis when abdominal pain develops in patients with ESKD, regardless of the presence of typical skin symptoms. Prompt detection and an integrated care approach are essential for improved prognosis. Further research is needed to find more efficacious treatments for this devastating illness.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11958865PMC
http://dx.doi.org/10.1007/s13730-024-00944-5DOI Listing

Publication Analysis

Top Keywords

gastrointestinal calciphylaxis
8
end-stage kidney
8
kidney disease
8
abdominal pain
8
calciphylaxis rare
4
rare devastating
4
devastating complication
4
complication end-stage
4
calciphylaxis
4
disease calciphylaxis
4

Similar Publications

Calciphylaxis, also known as calcific uremic arteriolopathy, is a rare and severe condition that predominantly affects individuals with end-stage kidney disease (ESKD). It manifests through vascular calcifications that precipitate tissue necrosis, with cutaneous manifestations being common. However, gastrointestinal involvement is an infrequent but gravely serious occurrence.

View Article and Find Full Text PDF
Article Synopsis
  • - Diets high in plant-based foods, rich in phytate, may benefit individuals with chronic kidney disease (CKD) by reducing phosphate absorption and other macrominerals, which some researchers see as an anti-nutrient due to phytate's binding properties.
  • - Phytate, which is not effectively degraded by the human intestine and poorly absorbed, has shown potential to decrease issues like vascular calcification, osteoporosis, and urinary stones in clinical studies, especially in patients undergoing hemodialysis.
  • - Beyond its effects on phosphate absorption, phytate may also provide anti-inflammatory and antioxidant benefits, and preliminary research suggests it could play a role in cancer suppression and cognitive health, although these claims require more rigorous clinical trials
View Article and Find Full Text PDF

Calciphylaxis is an infrequent yet lethal disease often associated with end-stage kidney disease (ESKD). The most common sites include proximal and distal extremities and the trunk, with few reported in the penis and very few as gastrointestinal (GI) disease. We report a case of systemic calciphylaxis in a middle-aged male, presenting with a colostomy leak and parastomal abscess.

View Article and Find Full Text PDF

Hydrogen Sulfide Metabolite, Sodium Thiosulfate: Clinical Applications and Underlying Molecular Mechanisms.

Int J Mol Sci

June 2021

Matthew Mailing Center for Translational Transplant Studies, London Health Sciences Center, Western University, London, ON N6A 5A5, Canada.

Thiosulfate in the form of sodium thiosulfate (STS) is a major oxidation product of hydrogen sulfide (HS), an endogenous signaling molecule and the third member of the gasotransmitter family. STS is currently used in the clinical treatment of acute cyanide poisoning, cisplatin toxicities in cancer therapy, and calciphylaxis in dialysis patients. Burgeoning evidence show that STS has antioxidant and anti-inflammatory properties, making it a potential therapeutic candidate molecule that can target multiple molecular pathways in various diseases and drug-induced toxicities.

View Article and Find Full Text PDF

Gastrointestinal Manifestations in a Patient with Calciphylaxis: A Case Report.

Case Rep Nephrol Dial

August 2019

Department of Renal Medicine, Wide Bay Hospital and Health Service, Bundaberg, Queensland, Australia.

Calciphylaxis is a rare condition usually seen in patients with significant renal disease, affecting 1-4' of patients undergoing haemodialysis. Although the disease usually manifests as lesions in the subcutaneous tissue, there have been rare occurrences of calciphylaxis presenting as lesions in the gastrointestinal tract, leading to complications of bowel necrosis and haemorrhage. In view of this, we report the case of suspected gastrointestinal tract calciphylaxis in a 63-year-old patient with end-stage kidney disease (ESKD) who presented with painful swelling in the medial and lateral aspect of both thighs.

View Article and Find Full Text PDF